A Phase 1 Study of VG-3927 in Healthy Adults and Patients With Alzheimer's Disease

Inclusion Criteria: * The participant is deemed healthy by the principal investigator, as determined by prestudy medical evaluation * The participant voluntarily agrees to participate in this study and signs an institutional review board approved informed consent Exclusion Criteria: * The participant has any concurrent disease or condition that, in the opinion of the principal investigator, would make the participant unsuitable for participation in the clinical study